Prevention of exacerbations of COPD with pharmacotherapy

by M. Miravitlles
Published 2010-06-01

Towards a patient-oriented treatment of COPD

by M. Miravitlles
Published 2016-03-01

Implementation of European Alpha-1 Research Collaboration (EARCO) in Portugal: the future starts now

by M. Sucena, J. Gomes, C. Guimarães, M. Miravitlles
Published 2020-07-01

Diagnosis of alpha1-antitrypsin deficiency not just in severe COPD

by A. Nuñez, M. Barrecheguren, E. Rodríguez, M. Miravitlles, C. Esquinas
Published 2018-11-01

Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulm...

by M. T. Driessen, J. Whalen, B. Seewoodharry Buguth, L. A. Vallejo-Aparicio, I. P. Naya, Y. Asukai, B. Alcázar-Navarrete, M. Miravitlles, F. García-Río, N. A. Risebrough
Published 2019-01-01

Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease:...

by M. T. Driessen, J. Whalen, B. Seewoodharry Buguth, L. A. Vallejo-Aparicio, I. P. Naya, Y. Asukai, B. Alcázar-Navarrete, M. Miravitlles, F. García-Río, N. A. Risebrough
Published 2018-11-01

Severe loss of mechanical efficiency in COVID‐19 patients

by Eulogio Pleguezuelos, Amin Del Carmen, Gemma Llorensi, Jessica Carcole, Paula Casarramona, Eva Moreno, Pilar Ortega, Mateo Serra‐Prat, Elisabet Palomera, Marc M. Miravitlles, Joan Carles Yebenes, Ramón Boixeda, Lluis Campins, Koldo Villelabeitia‐Jaureguizar, Manuel Vicente Garnacho‐Castaño
Published 2021-08-01